0Suppliers
0Customers
3Debt Items
12Related Chains
Bio-Path Holdings, Inc. Suppliers
No suppliers on recordBio-Path Holdings, Inc. has not yet been matched to upstream suppliers in our database, or is still being processed.
Bio-Path Holdings, Inc. Customers
No clients on recordNo downstream customers found in our database for Bio-Path Holdings, Inc..
Bio-Path Holdings, Inc. Debt Obligations
| Instrument | Description | Confidence | Evidence |
|---|
| BPTH-DEBT |
Debt stack $463,000 |
90%
|
Market cache reports total debt of $463,000. |
| BPTH-DEBT-8348 |
Xbrl Convertible |
90%
|
xbrl convertible detail from xbrl 2025-09-30. |
| BPTH-DEBT-8347 |
Warrants outstanding: 44625 |
90%
|
xbrl warrant detail from xbrl 2024-12-31. |
Bio-Path Holdings, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Bio-Path Holdings, Inc..
Bio-Path Holdings, Inc. Ownership
| Holder | Name | Confidence | Evidence |
|---|
| BPTH-OWNER-DANSKE-BANK-A-S |
DANSKE BANK A/S |
90%
|
13F overlay lists DANSKE BANK A/S as top holder; 1 tracked holders. |
Bio-Path Holdings, Inc. Extended Supply Chain Network
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|
| LLY |
Eli Lilly and Company |
100.00 |
2 |
|
| STTK |
Shattuck Labs, Inc. |
100.00 |
2 |
|
| GILD |
Gilead Sciences, Inc. |
100.00 |
2 |
|
| NRIX |
Nurix Therapeutics, Inc. |
100.00 |
2 |
|
| SNYNF |
Sanofi |
100.00 |
2 |
|
| RNAZ |
TransCode Therapeutics, Inc. |
100.00 |
2 |
|
| VINC |
Vincerx Pharma, Inc. |
100.00 |
2 |
|
| RIGL |
Rigel Pharmaceuticals, Inc. |
100.00 |
2 |
|
| JNJ |
Johnson & Johnson |
100.00 |
2 |
|
| CYTOF |
Altamira Therapeutics Ltd. |
36.29 |
1 |
['spend'] |
| CRIS |
Curis, Inc. |
36.29 |
1 |
['spend'] |
| ROCHE |
ROCHE |
23.09 |
2 |
|
